References
- ZuoQFYangLYFengQEvaluation of the protective immunity of a novel subunit fusion vaccine in a murine model of systemic MRSA infectionPLoS One2013812e8121224324681
- ZhaoZLiBSunHQFine-mapping of immunodominant linear B-cell epitopes of the Staphylococcus aureus SEB antigen using short overlapping peptidesPLoS One201493e9044524599257
- MorefieldGTouheyGLuFDunhamAHogenEschHDevelopment of a recombinant fusion protein vaccine formulation to protect against Streptococcus pyogenesVaccine201432303810381524837509
- ZhangWWangLLiuYImmune responses to vaccines involving a combined antigen-nanoparticle mixture and nanoparticle-encapsulated antigen formulationBiomaterials201435236086609724780166
- ChenWLLiuSJLengCHChenHWChongPHuangMHDisintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactideBiomaterials20143551686169524268203
- DengJCaiWJinFA novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluationInt J Pharm20144681–218719524704309
- XuLLiuYChenZSurface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatmentNano Lett20121242003201222372996
- ShiRHongLWuDEnhanced immune response to gastric cancer specific antigen Peptide by coencapsulation with CpG oligodeoxynucleotides in nanoemulsionCancer Biol Ther20054221822415753659
- LindellDMMorrisSBWhiteMPA novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced diseasePLoS One201167e2182321789184
- MakidonPEBelyakovIMBlancoLPNanoemulsion mucosal adjuvant uniquely activates cytokine production by nasal ciliated epithelium and induces dendritic cell traffickingEur J Immunol20124282073208622653620
- SunHLiuKLiuWDevelopment and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugsInt J Nanomed2012755295543
- CaiWDengWYangHChenXJinFA propofol microemulsion with low free propofol in the aqueous phase: formulation, physicochemical characterization, stability and pharmacokineticsInt J Pharm20124361–253654422814221
- MycAKukowska-LatalloJFBielinskaAUDevelopment of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsionVaccine20032125–263801381412922114
- ParkSLeeJBKangSTopical application of Chrysanthemum indicum L. attenuates the development of atopic dermatitis-like skin lesions by suppressing serum IgE levels, IFN-gamma, and IL-4 in Nc/Nga miceEvid Based Complement Alternat Med2012201282196722454686
- JafarzadehANematiMRezayatiMTEbrahimiMHassanZMCimetidine enhances delayed-type hypersensitivity responses and serum interleukin (IL)-2, -10, -12, and IL-17 levels after burn injury in an animal modelJ Immunotoxicol201310220120922946962
- KhodaverdianVPeshoMTruittBDiscovery of antivirulence agents against methicillin-resistant Staphylococcus aureusAntimicrob Agents Chemother20135783645365223689713
- HuaLHilliardJJShiYAssessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumoniaAntimicrob Agents Chemother20145821108111724295977
- MazmanianSKTon-ThatHSuKSchneewindOAn iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesisProc Natl Acad Sci U S A20029942293229811830639
- EbertTSmithSPancariGA fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivoHum Antibodies201019411312821178283
- LiangXJiYAlpha-toxin interferes with integrin-mediated adhesion and internalization of Staphylococcus aureus by epithelial cellsCell Microbiol20068101656166816984420
- MarrackPMcKeeASMunksMWTowards an understanding of the adjuvant action of aluminiumNat Rev Immunol20099428729319247370
- ZaharoffDARogersCJHanceKWSchlomJGreinerJWChitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccinationVaccine200725112085209417258843
- LeeSNguyenMTRecent advances of vaccine adjuvants for infectious diseasesImmune Netw2015152515725922593
- JiangJFisherEMHensleySELustigmanSMuraskoDMShenHAntigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccinesVaccine201432232696270224681229
- PeekLJMiddaughCRBerklandCNanotechnology in vaccine deliveryAdv Drug Deliv Rev200860891592818325628
- KalvodovaLSqualene-based oil-in-water emulsion adjuvants perturb metabolism of neutral lipids and enhance lipid droplet formationBiochem Biophys Res Commun2010393335035520018176
- BachmannMFJenningsGTVaccine delivery: a matter of size, geometry, kinetics and molecular patternsNat Rev Immunol2010101178779620948547
- SmithDMSimonJKBakerJRJrApplications of nanotechnology for immunologyNat Rev Immunol201313859260523883969
- SeubertAMonaciEPizzaMO’HaganDTWackAThe adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cellsJ Immunol200818085402541218390722
- MohanTVermaPRaoDNNovel adjuvants & delivery vehicles for vaccines development: a road aheadIndian J Med Res2013138577979524434331
- DasSCHattaMWilkerPRNanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccineVaccine201230486871687722989689